AAM
IDXX icon

Aberdeen Asset Management’s Idexx Laboratories IDXX Stock Holding History

Aberdeen Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2.46M Sell
15,253
-1,350
-8% -$219K 0.01% 572
2017
Q1 		$2.57M Buy
+16,603
New +$2.29M 0.01% 559

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Aberdeen Asset Management's IDXX Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Idexx Laboratories (IDXX) stake by 8.1% in Q2 2017, selling an estimated $219K and leaving 15,253 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #572.

Aberdeen Asset Management first reported a position in IDXX in Q1 2017 and has held it in 2 quarters since. The position peaked at $2.57M in Q1 2017. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.

  • Aberdeen Asset Management held 15,253 shares of Idexx Laboratories worth $2.46M as of Q2 2017.
  • Aberdeen Asset Management sold 1,350 Idexx Laboratories shares in Q2 2017, an estimated $219K.
  • Idexx Laboratories made up 0.01% of Aberdeen Asset Management's portfolio in Q2 2017, its #572 holding.
  • Aberdeen Asset Management first reported a position in Idexx Laboratories in Q1 2017 and has held it in 2 quarters since.
  • Aberdeen Asset Management's Idexx Laboratories position peaked at $2.57M in Q1 2017.
  • 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.